Beijing, China

Liufeng Zhou



 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Liufeng Zhou: Innovator in Pharmaceutical Compounds

Introduction

Liufeng Zhou is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. His work has led to the granting of multiple patents, showcasing his innovative approach to drug development.

Latest Patents

Liufeng Zhou holds two recent patents that highlight his expertise. The first patent is titled "Crystalline form of fused pyridine derivative's maleate and uses thereof." This patent provides a detailed description of the compound of Formula I, its crystalline form, and methods for preparing and utilizing it. The second patent is focused on "Stable polymorphic forms of compound as hypoxia mimetics, and uses thereof." This patent discloses the polymorphic forms of the compound of Formula I, including the preparation of intermediates, pharmaceutical compositions, and their applications in manufacturing medicaments for treating various diseases, disorders, or conditions.

Career Highlights

Throughout his career, Liufeng Zhou has worked with prominent companies in the pharmaceutical industry. He has been associated with Beijing Betta Pharmaceuticals Co., Ltd and Betta Pharmaceuticals Co., Ltd, where he has contributed to the advancement of pharmaceutical research and development.

Collaborations

Liufeng Zhou has collaborated with several professionals in his field, including Wei Long and Fei Wang. These collaborations have further enriched his research and innovation efforts.

Conclusion

Liufeng Zhou's contributions to pharmaceutical innovations through his patents and collaborations underscore his role as a significant inventor in the industry. His work continues to impact the development of new therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…